Skip to content

Author

Han-Zhang Xu

We have 3 of 71 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Ubiquitin-specific protease 48: Molecular mechanisms, pathophysiological roles and therapeutic potential.

Current advances in USP48 structure, substrate specificity, molecular mechanisms, and disease-specific functions are synthesized to provide a critical evaluation of preclinical USP48-targeted therapeutic strategies, and delineate the major conceptual and translational challenges impeding the clinical development of USP...

Hu Lei, Chujiao Zhu, Li Yang et al. · 1 citation
Open access Aug 2026

Identification of YL064 as a novel inhibitor of ATXN3 to suppress tumor growth and metastasis by promoting degradation of oncogenic substrates

YL064 is established as a promising ATXN3 inhibitor that targets the ubiquitin-proteasome pathway to exert anti-tumor effects, highlighting its potential as a novel therapeutic agent for ATXN3-driven cancers.

Zhenge Zhang, Wenhui Bai, Yayue Tan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.